EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

salts of aniline

EC / List no: - CAS no: -
EU CLP (1272/2008)
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1

Help Help
Group members
This group of substance has the following member substances:
Results list is empty
Name EC / List no. CAS no. Association
Anilinium acetate 208-802-4 542-14-3 Expert judgement
Anilinium dihydrogen phosphate 253-680-8 37832-42-1 Expert judgement
Benzenesulfonic acid, 2(or 4)-methyl-, compd. with benzenamine (1:1) - 70788-38-4 Expert judgement
Anilinetrifluoroboron 211-539-8 660-53-7 Expert judgement
Anilinium chloride 205-519-8 142-04-1 Expert judgement
Anilinium p-tolylsulphonate 237-870-8 14034-57-2 Expert judgement
Phthalic acid, compound with aniline (1:1) 256-856-2 50930-79-5 Expert judgement
Benzenesulfonic acid, 2,2'-dithiobis(5-methyl-, compd. with benzenamine (1:2) - 63468-80-4 Expert judgement
Anilinium bromide 208-801-9 542-11-0 Expert judgement
Dianilinium sulphate 208-805-0 542-16-5 Expert judgement
Aniline 200-539-3 62-53-3 Expert judgement